Humana ETF Leadership
HUM Etf | USD 315.98 12.00 3.66% |
Humana employs about 67.6 K people. The company is managed by 75 executives with a total tenure of roughly 452 years, averaging almost 6.0 years of service per executive, having 901.33 employees per reported executive. Analysis of Humana's management performance can provide insight into the ETF performance.
David Jones Director Independent Director |
Kurt Hilzinger Chairman Independent Chairman of the Board |
Humana's Insider Buying Vs Selling
50
Selling | Buying |
Latest Trades
2024-02-20 | Jorge S Mesquita | Acquired 545 @ 367.09 | View | ||
2023-05-04 | Susan M Diamond | Disposed 4156 @ 526.28 | View |
Monitoring Humana's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Humana |
Humana Management Team Effectiveness
The company has Return on Asset of 0.0634 % which means that on every $100 spent on assets, it made $0.0634 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1568 %, implying that it generated $0.1568 on every 100 dollars invested. Humana's management efficiency ratios could be used to measure how well Humana manages its routine affairs as well as how well it operates its assets and liabilities.Humana Workforce Comparison
Humana Inc is rated below average in number of employees as compared to similar ETFs. The total workforce of Health Care category is currently estimated at about 989,061. Humana holds roughly 67,600 in number of employees claiming about 7% of all ETFs under Health Care category.
The company has Net Profit Margin of 0.02 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. Humana Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Humana Inc Price Series Summation is a cross summation of Humana price series and its benchmark/peer.
Humana Notable Stakeholders
A Humana stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Humana often face trade-offs trying to please all of them. Humana's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Humana's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kurt Hilzinger | Independent Chairman of the Board | Profile | |
Bruce Broussard | CEO and President Director and Chairman of Executive Committee | Profile | |
Roy Beveridge | Senior Vice President Chief Medical Officer | Profile | |
Cynthia Zipperle | Senior Vice President, Chief Accounting Officer, Controller | Profile | |
Alan Wheatley | Segment President - Retail | Profile | |
James MBA | President COO | Profile | |
Christopher Hunter | Segment President, Group and Military Business | Profile | |
Susan Diamond | Chief Financial Officer, Segment President, Home Business | Profile | |
Bruce Perkins | President - Health and Well-Being Services Segment | Profile | |
David Dintenfass | President Growth | Profile | |
John III | Senior President | Profile | |
Christopher Todoroff | Senior Vice President General Counsel | Profile | |
William Fleming | Segment President, Pharmacy Solutions and Chief Corporate Affairs Officer | Profile | |
Thomas Liston | President - Retail Segment | Profile | |
Bethanie Stein | President Pharmacy | Profile | |
Betty Assapimonwait | President - Humana's South Florida Medicare | Profile | |
Elizabeth Bierbower | President - Employer Group Segment | Profile | |
Christopher Kay | Chief Innovation Officer, Senior Vice President | Profile | |
George II | President Medicaid | Profile | |
Heidi Margulis | Senior Vice President - Public Affairs | Profile | |
MD MBA | President CenterWell | Profile | |
Regina Nethery | Vice President - Investor Relations | Profile | |
Tim McClain | President - Government and Other Businesses | Profile | |
Brian LeClaire | Senior Vice President CIO | Profile | |
Brian Kane | Chief Financial Officer | Profile | |
James Murray | COO and Executive VP | Profile | |
Sam Deshpande | Chief Technology Officer, Chief Risk Officer | Profile | |
Eric Tagliere | Senior CTO | Profile | |
Jody Bilney | Chief Consumer Officer and Sr. VP | Profile | |
David Jones | Independent Director | Profile | |
David Nash | Independent Director | Profile | |
David Feinberg | Independent Director | Profile | |
Marissa Peterson | Independent Director | Profile | |
James Brien | Independent Director | Profile | |
James OBrien | Independent Director | Profile | |
William Mitchell | Independent Director | Profile | |
Frank DAmelio | Independent Director | Profile | |
Frank Bisignano | Independent Director | Profile | |
Karen DeSalvo | Independent Director | Profile | |
Roy Dunbar | Independent Director | Profile | |
William McDonald | Independent Director | Profile | |
Karen Katz | Independent Director | Profile | |
Joseph Ventura | Chief Legal Officer and Corporate Secretary | Profile | |
Vishal MD | Chief Officer | Profile | |
Susan Schick | Segment President Group and Military Business | Profile | |
Raquel Bono | Independent Director | Profile | |
Jorge Mesquita | Independent Director | Profile | |
W Dunbar | Independent Director | Profile | |
Heather Carroll | Chief Digital Health and Analytics Officer | Profile | |
Kate Goodrich | Senior Officer | Profile | |
Timothy Wheatley | Segment Retail | Profile | |
Andrew Agwunobi | President - Home Solutions Business | Profile | |
Steven McCulley | Chief Accounting Officer | Profile | |
Heather Cox | Chief Digital Health and Analytics Officer | Profile | |
Jessica Clark | Senior Improvement | Profile | |
Jennifer Bazante | Chief Marketing Officer | Profile | |
Amy Fry | Sr Communications | Profile | |
Marcy Klevorn | Independent Director | Profile | |
Nwando Olayiwola | Senior Vice President Chief Health Equity Officer | Profile | |
Vishal Agrawal | Chief Strategy and Corporate Development Officer | Profile | |
Wayne Frederick | Independent Director | Profile | |
PharmD PharmD | Chief Solutions | Profile | |
Erin Champlin | Senior Experience | Profile | |
Timothy Huval | Chief Human Resource Officer, Chief Administrative Officer | Profile | |
Sue Schick | President - Military and Specialty Businesses | Profile | |
T Wheatley | Segment President - Retail | Profile | |
Tracy Nolan | Senior MarketPoint | Profile | |
Samir Deshpande | Chief Information Officer | Profile | |
William Shrank | Chief Medical and Corporate Affairs Officer | Profile | |
John Garratt | Independent Director | Profile | |
Carolyn Tandy | Senior Vice President and Chief Inclusion and Diversity Officer | Profile | |
Jay Khosla | Senior Officer | Profile | |
JohnPaul Felter | Chief VP | Profile | |
Lisa Stoner | Vice Relations | Profile | |
Michael Koeberlein | Senior Vice President Chief Accounting Officer, Controller | Profile |
About Humana Management Performance
The success or failure of an entity such as Humana Inc often depends on how effective the management is. Humana management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Humana management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Humana management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. Humana operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 95500 people.
The data published in Humana's official financial statements usually reflect Humana's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Humana Inc. For example, before you start analyzing numbers published by Humana accountants, it's critical to develop an understanding of what Humana's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Humana's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Humana's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Humana's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Humana Inc. Please utilize our Beneish M Score to check the likelihood of Humana's management manipulating its earnings.
Humana Workforce Analysis
Traditionally, organizations such as Humana use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Humana within its industry.Humana Manpower Efficiency
Return on Humana Manpower
Revenue Per Employee | 1.6M | |
Revenue Per Executive | 1.4B | |
Net Income Per Employee | 36.8K | |
Net Income Per Executive | 33.2M | |
Working Capital Per Employee | 5.4K | |
Working Capital Per Executive | 4.9M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humana Inc. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
The market value of Humana Inc is measured differently than its book value, which is the value of Humana that is recorded on the company's balance sheet. Investors also form their own opinion of Humana's value that differs from its market value or its book value, called intrinsic value, which is Humana's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Humana's market value can be influenced by many factors that don't directly affect Humana's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Humana's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humana is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humana's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.